During the past decade, Health Research of Hampton Roads, Inc. conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 18 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 15 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Health Research of Hampton Roads, Inc." #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Novartis" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Allergan" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Health Research of Hampton Roads, Inc." #1 collaborator was "Daré Bioscience, Inc." with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Novum Pharmaceutical Research Services" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Health Research of Hampton Roads, Inc." are "Migraine" (5 trials), "Obesity" (4 trials), "Overweight" (4 trials), "Chronic Idiopathic Constipation" (3 trials) and "Acute Gout" (2 trials). Many other conditions were trialed in "Health Research of Hampton Roads, Inc." in a lesser frequency.

Most popular intervention types in "Health Research of Hampton Roads, Inc." are "Drug" (41 trials), "Other" (6 trials), "Biological" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Galcanezumab" (3 trials), "Tirzepatide" (3 trials), "Atogepant" (2 trials) and "Celecoxib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Health Research of Hampton Roads, Inc." are 42 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Health Research of Hampton Roads, Inc.". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Health Research of Hampton Roads, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Health Research of Hampton Roads, Inc., 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".